– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patient...
〜Driving Technology Transfer and Test Manufacturing Following Regulatory Approval to Launch Company...
TOKYO, June 30, 2025 /PRNewswire/ -- Alpha Fusion, Inc. ("Alpha Fusion") and Curadh MTR Inc. ("Cur...
OSAKA, Japan, Oct. 9, 2024 /PRNewswire/ -- Alpha Fusion, Inc. (CEO: Sunao Fujioka, headquartered in...